1. Home
  2. MRSH vs BSX Comparison

MRSH vs BSX Comparison

Compare MRSH & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MRSH

Marsh Common Stock

N/A

Current Price

$178.86

Market Cap

84.3B

Sector

Finance

ML Signal

N/A

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$44.78

Market Cap

93.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRSH
BSX
Founded
1871
1979
Country
United States
United States
Employees
55700
N/A
Industry
Specialty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.3B
93.4B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
MRSH
BSX
Price
$178.86
$44.78
Analyst Decision
Hold
Strong Buy
Analyst Count
11
22
Target Price
$199.27
$93.18
AVG Volume (30 Days)
2.3M
20.4M
Earning Date
04-16-2026
04-22-2026
Dividend Yield
2.11%
N/A
EPS Growth
N/A
55.20
EPS
N/A
0.90
Revenue
N/A
$9,076,000,000.00
Revenue This Year
$6.85
$11.85
Revenue Next Year
$4.70
$10.16
P/E Ratio
$21.13
$50.38
Revenue Growth
N/A
12.49
52 Week Low
$156.60
$42.25
52 Week High
$193.32
$109.50

Technical Indicators

Market Signals
Indicator
MRSH
BSX
Relative Strength Index (RSI) 63.75 38.76
Support Level $175.45 $42.25
Resistance Level $185.54 $50.14
Average True Range (ATR) 4.65 1.40
MACD 1.59 0.43
Stochastic Oscillator 94.25 50.84

Price Performance

Historical Comparison
MRSH
BSX

About MRSH Marsh Common Stock

Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: